1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid TumorsSolid TumorActive, not recruitingPhase 22025-10-14NCT05642780